These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15941682)

  • 1. High levels of circulating interleukin-10 in diabetic nephropathy patients.
    Myśliwska J; Zorena K; Semetkowska-Jurkiewicz E; Rachoń D; Suchanek H; Myśliwski A
    Eur Cytokine Netw; 2005 Jun; 16(2):117-22. PubMed ID: 15941682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
    Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum levels of interleukin-18 in patients with diabetic nephropathy.
    Mahmoud RA; el-Ezz SA; Hegazy AS
    Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
    Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.
    Lee SH; Lee TW; Ihm CG; Kim MJ; Woo JT; Chung JH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S32-6. PubMed ID: 16174285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus.
    Suchanek H; Myśliwska J; Siebert J; Wieckiewicz J; Hak Ł; Szyndler K; Kartanowicz D
    Eur Cytokine Netw; 2005 Sep; 16(3):177-85. PubMed ID: 16266856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes.
    Canani LH; Costa LA; Crispim D; Gonçalves Dos Santos K; Roisenberg I; Lisbôa HR; Sarturi Tres G; Maia AL; Gross JL
    Diabet Med; 2005 Sep; 22(9):1167-72. PubMed ID: 16108844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF; Milena FJ; Mora C; León C; García J
    Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial factors in diabetic nephropathy: an offspring study.
    Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
    Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL; Wu J; Guo LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
    Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
    Ngarmukos C; Bunnag P; Kosachunhanun N; Krittiyawong S; Leelawatana R; Prathipanawatr T; Plengvidhya N; Benjasuratwong Y; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S37-42. PubMed ID: 17715832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.